Gottsegen National Cardiovascular Center

facility HU

Publications

990

Citations

Researchers

Publications

View All

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

John H. Alexander , Renato D. Lópes , Stefan James +31 more

The addition of apixaban, at a dose of 5 mg twice daily, to antiplatelet therapy in high-risk patients after an acute coronary syndrome increased the number of major bleeding ev...

2011 New England Journal of Medicine 990 citations

Affiliated Researchers

Mátyás Keltai

Gottsegen National Cardiovascular Center

Institution Info

Type: facility
Country: HU
Publications: 1
Citations: 990

External Links

Identifiers

ROR: https://ror.org/04r60ve96